SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Equipment >

InspireMD, Inc. (NSPR)

NSPR RSS Feed
Add NSPR Price Alert      Hide Sticky   Hide Intro
Moderator: pennystock_es, Value_Investor
Search This Board: 
Last Post: 7/20/2017 12:43:03 PM - Followers: 57 - Board type: Free - Posts Today: 0

 

Great Europe-Patent News for NSPR (01.05.2017):
 https://register.epo.org/application?number=EP07827415

NSPR is still one of the Cheapest NYSE stocks based on the New BV & CV! The 10-Q confirms its 100% Debt-Free financial status which is the most important fundamental for a big board stock ! 

https://register.epo.org/application?number=EP07827415 
https://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-113000992.html 
http://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-110000931.html 
http://finance.yahoo.com/news/inspiremd-cguard-tm-embolic-prevention-133200180.html 
http://www.marketwatch.com/story/inspiremd-repays-term-note-ahead-of-schedule-2017-03-22?siteid=bigcharts&dist=bigcharts 


InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.

Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
 

Our Technology

MicroNetTM

The MicroNet is a bio-stable mesh woven from a single strand of 20 μm Polyethylene Terephthalate (PET). The MicroNet is designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization.

MicroNetTM key features:

  • PET is a bio-stable synthetic fiber widely used in a variety of industries.
    Attached and secured to the proximal and the distal crowns of the stent.
    Does not alter the procedure as it expands with the stent.
    Pore size is typically between 150 – 180 µm. 
     

CGuard™

need for tapered version


Carotid Embolic Prevention System

The CGuardTM Embolic Prevention System (EPS) is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.

Product Details:

  • CGuard material: Nitinol
MicroNet material: Polyethylene Terephthalate (PET)
  • Easy to use RX (Rapid Exchange) delivery system
     

MGuard™

Improving Clinical Outcomes For STEMI Patients

The MGuardTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization and optimize flow.

While offering performance that is superior to standard STEMI therapy, MGuard requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard material: Stainless Steel 316 
  • MicroNet material: Polyethylene Terephthalate (PET)

     

MGuard Prime™

Improving Clinical Outcomes For STEMI Patients

The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.

While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard Prime material: Cobalt Chromium (CoCr) L605

MicroNet material: Polyethylene Terephthalate (PET)
  • Superior flexibility and excellent deliverability

http://www.inspiremd.com/en/products/the-technology/
 

2017 News

Thursday23March 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia

BOSTON, MA—March 23, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its…

Wednesday22March 2017

InspireMD Repays Term Note Ahead of Schedule

Tel Aviv—March 22, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that…

Tuesday21March 2017

InspireMD Announces Distribution Agreement for CGuard™ EPS in Hong Kong

BOSTON, MA—March 21, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Monday20March 2017

InspireMD Announces CGuardTM Distribution Agreement for the Russian Federation

Tel Aviv—March 20, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Wednesday15March 2017

InspireMD Reports Continued Progress in the Transition of European Sales and Distribution

Announces Agreements with Leading Distributors in the Baltic States   BOSTON, MA—March 15, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS)…

Tuesday14March 2017

InspireMD Announces Closing of Public Offering of Approximately $6.8 Million

BOSTON, MA – March 14, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday09March 2017

InspireMD Announces Pricing of Public Offering of up to $7.5 Million

BOSTON, MA – March 9, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday16February 2017

InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Transition from Exclusive Distribution Partner to Local Distributors and Internal Sales Strategy Validated by Strong Revenue Growth in Select Markets   BOSTON, MA—February 16, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS)…

Tuesday24January 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at LINC 2017

PD Dr. Andrej Schmidt to perform live case transmission of carotid stent surgery utilizing CGuard™ BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a…

Contact Us

Thank you for your interest in InspireMD, please let us know how we can help you. You can contact us at info@inspiremd.com or 1-888-776-6804.

Executives

James J. BarryPresident & Chief Executive Officer

Dr. Barry has over 20 years of experience in the medical device industry. Prior to joining InspireMD, he was the President and CEO of Arsenal Medical, a life sciences company…

Craig ShoreChief Financial Officer

Mr. Shore has over 25 years of experience in financial management in the United States, Europe and Israel. He has served in various senior financial and general management roles at…

Agustin GagoExecutive Vice President and Chief Commercial Officer

Mr. Gago has over 25 years of experience in building profitable international commercial, sales and marketing organizations. Prior to joining InspireMD, he was the founder and principal of Dash International…

Benzi SpectorHead of R&D and Operations

Mr. Spector has more than 25 years of experience in research, development and engineering, serving as the lead on a range of product lines and systems in the healthcare space….

Sharon ShacharHead of Regulatory and Quality

Mrs. Shachar has over 12 years of experience in quality, regulatory and clinical execution, serving in executive roles in small and large medical companies.   Prior to joining InspireMD, she…

Website:  http://www.inspiremd.com/en/

 

NSPR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#935  Sticky Note NSPR is Up Strongly (5.42%) in the After-Hour Value_Investor 07/13/17 08:45:10 PM
#941   Yes. NSPR has built a Higher low 0.4603 Value_Investor 07/20/17 12:43:03 PM
#939   Nice to see NSPR rise to $0.538 today! Value_Investor 07/19/17 11:44:57 PM
#938   Another New low $0.40 will be a "New Value_Investor 07/15/17 02:31:22 PM
#937   0.50 ended up as not being a floor. Rymankoly 07/14/17 03:52:19 PM
#936   Is .45 the new .50? Someone keeping a JenningsB 07/14/17 03:21:07 PM
#935   NSPR is Up Strongly (5.42%) in the After-Hour Value_Investor 07/13/17 08:45:10 PM
#934   Even I got some today.....hope stop won't kick in... Rymankoly 07/13/17 02:45:52 PM
#933   Me too. NSPR is Hyper Oversold today --- Value_Investor 07/13/17 01:40:39 PM
#932   Looks like the Buying indicator was mitigated by Rymankoly 07/12/17 11:10:12 AM
#931   Adding! NSPR stock777777 07/11/17 01:30:48 PM
#930   Yes. NSPR is Hyper Oversold now --- it Value_Investor 07/11/17 12:49:57 PM
#928   LOL, NSPR crashed to $0.5301 with 2,900 shares Value_Investor 07/05/17 07:57:24 PM
#927   Looks like buying indicator just kicked in !!! Rymankoly 07/05/17 10:56:02 AM
#926   NSPR just crashed to $0.55! Are you kidding? Value_Investor 07/05/17 10:39:34 AM
#925   This week $ 1.5? pennystock_es 07/03/17 04:10:45 AM
#924   looking good here. Buying some more for next aristotelisonassis 06/30/17 04:33:41 PM
#923   Wheeeee gappa and runna next week! BERKSHIRE AGENT 06/30/17 04:29:21 PM
#922   Buying NSPR Today! stock777777 06/30/17 11:41:41 AM
#921   Almost ready! NSPR stock777777 06/30/17 09:24:42 AM
#920   Total 529,600 shares or 7.35% of OS were Value_Investor 06/26/17 06:31:48 PM
#918   Up 5.4% today! Also Thousands of shares Slapped Value_Investor 06/15/17 06:27:26 PM
#917   Another Good News kicked in today --- see Value_Investor 06/15/17 04:15:47 PM
#916   Another Good News kicked in this morning --- Value_Investor 06/13/17 08:44:05 AM
#915   Hopefully on next Monday we hear some similar Value_Investor 06/09/17 03:57:57 PM
#913   Yes. Another Good News just kicked in today Value_Investor 06/09/17 07:46:21 AM
#911   NSPR went up to $0.64 this early morning Value_Investor 06/08/17 11:17:41 PM
#910   Another Good News (the first link below) kicked Value_Investor 06/08/17 12:22:18 PM
#909   News for a spike. Lucky who sold PM Memus 06/08/17 09:37:00 AM
#908   sold out my entire position yesterday.. many better bill_y 06/08/17 07:09:14 AM
#907   There you go again. Maybe in a year CIMA7 06/07/17 04:26:07 PM
#906   Another Good News (the first link below) kicked Value_Investor 06/07/17 01:08:54 PM
#905   Total 396,310 shares or 5.5% of float were Value_Investor 06/05/17 06:24:56 PM
#904   NSPR has another Good News today --- see Value_Investor 06/05/17 10:19:00 AM
#903   Another Important News for NSPR today --- New Value_Investor 06/02/17 11:04:08 AM
#902   0.50 coming Memus 06/01/17 10:12:28 AM
#901   NSPR has another Good News today which will Value_Investor 06/01/17 08:56:38 AM
#900   Told you: downtrend. Hitting 52w low again. New Memus 05/31/17 11:27:13 AM
#899   The Chinese market is endless .... GO $NSPR pennystock_es 05/31/17 11:17:57 AM
#898   Bought 2k for fun xfrozenx 05/30/17 09:46:19 AM
#897   Huge news going to dollars! Wreckingballer 05/30/17 09:17:20 AM
#896   News !! $Nspr InspireMD Announces First Two Patients pennystock_es 05/30/17 08:51:29 AM
#895   garyev..thanks very positive news..brighter days ahead.. bill_y 05/30/17 08:46:31 AM
#894   https://www.otcmarkets.com/stock/NSPR/news garyev 05/30/17 08:41:53 AM
#893   big pre market trading today..whats up.. bill_y 05/30/17 08:32:25 AM
#892   Good because you only make money looking forward. Wreckingballer 05/29/17 05:33:02 PM
#891   Sure do. Rymankoly 05/29/17 04:49:40 PM
#890   Lol 2014. You do realize it's 2017 now? Wreckingballer 05/29/17 02:30:18 PM
#889   True, always do DD and learn some history...: Rymankoly 05/29/17 02:05:13 PM
#888   Always do your DD. Wreckingballer 05/29/17 12:16:32 PM
#887   Wrong again. Please go Google what the NYSE Wreckingballer 05/29/17 11:58:00 AM
PostSubject